Systematic Review
Accepted on 28 Nov 2023
Efficacy and Safety of Metformin for Melasma Treatment: A Systematic Review and Meta-Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1281050
Type at least 3 characters
1,724 articles
Articles
Original Research
Published on 28 Nov 2023
Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1199500
- 1,289 views
Perspective
Published on 28 Nov 2023
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1274532
- 205 views
Original Research
Accepted on 27 Nov 2023
Minding the Gaps: Assessing and addressing clinical research core competencies across a network of Canadian cancer centres
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1294335
Opinion
Published on 24 Nov 2023
Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1276396
- 301 views
Methods
Published on 24 Nov 2023
Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1249998
- 475 views
Review
Published on 23 Nov 2023
Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1261312
- 596 views
Original Research
Accepted on 22 Nov 2023
Online information and availability of three doping substances (anabolic agents) in sports: role of pharmacies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1305080
Original Research
Published on 22 Nov 2023
Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1266322
- 513 views
Correction
Published on 22 Nov 2023
Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1336072
- 153 views
Original Research
Accepted on 21 Nov 2023
Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: A marginal structural model causal analyse Running head: Heparin improves outcomes in solid malignancy associated sepsis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1281235
Original Research
Accepted on 21 Nov 2023
A Cross-Sectional Study of Appropriateness Evaluation of Anticoagulation Therapy for Inpatients with Nonvalvular Atrial Fibrillation
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1286559
Original Research
Published on 21 Nov 2023
Healthcare professional perspectives on medication challenges in the post-stroke patient
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1266277
- 310 views
Original Research
Published on 21 Nov 2023
Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1268793
- 182 views
Editorial
Published on 21 Nov 2023
Editorial: Effective methods to promote appropriate use of medicines
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1331906
- 306 views
Original Research
Accepted on 20 Nov 2023
Physical activity influences adherence to pharmacological treatments in patients with severe mental disorders: results from the multicentric, randomized controlled LIFESTYLE trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285383